Optomed Plc: interim report, January – September 2020
Optomed Plc Stock Exchange Release 25 November 2020 at 9.00, Helsinki Optomed Plc: interim report, January – September 2020 July – September 2020 · Revenue decreased by 6.0 percent to EUR 3,338 (3,551) thousand · EBITDA, gross profit, and gross margin all increased · Adjusted EBITDA amounted to EUR 229 (-160) thousand corresponding to 6.9 (-4.5) percent of revenue · The COVID-19 pandemic continued to negatively affect the Devices segment revenue, whereas the Software segment continues its solid performance · Major Chinese customer continued purchases